SecSonar.com

Ascentage Pharma Group International (AAPG)

Ascentage Pharma Group International at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Ascentage Pharma Group International (AAPG) is a Biotechnology company based in CN with a market capitalization of $1.9B. Revenue declined 43.0% year-over-year and free cash flow was negative at -$1.2B. This page tracks AAPG's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CN · 567 employees · IPO Jan 24, 2025

Valuation

Valuation & price

$20.38 · as of May 26, 2026 · -57.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$47.70$32.23$16.77Jul 25Dec 25Jul 26Jul 7, 25$42.04Jul 9, 25$41.87Jul 11, 25$38.24Jul 15, 25$36.76Jul 17, 25$39.62Jul 21, 25$39.71Jul 23, 25$38.31Jul 25, 25$37.80Jul 29, 25$40.08Jul 31, 25$37.00Aug 4, 25$37.60Aug 6, 25$42.68Aug 11, 25$40.04Aug 13, 25$41.15Aug 15, 25$45.00Aug 19, 25$46.40Aug 21, 25$47.70Aug 25, 25$43.48Aug 27, 25$41.40Aug 29, 25$42.47Sep 3, 25$41.31Sep 5, 25$40.50Sep 9, 25$40.40Sep 11, 25$39.89Sep 16, 25$39.21Sep 18, 25$39.35Sep 22, 25$38.31Sep 24, 25$37.41Sep 26, 25$37.33Sep 30, 25$39.04Oct 2, 25$39.78Oct 6, 25$39.86Oct 8, 25$40.23Oct 10, 25$34.94Oct 14, 25$35.07Oct 16, 25$36.46Oct 21, 25$34.46Oct 23, 25$34.08Oct 27, 25$34.56Oct 29, 25$33.40Oct 31, 25$33.42Nov 4, 25$33.25Nov 6, 25$32.36Nov 10, 25$32.40Nov 12, 25$32.95Nov 14, 25$34.30Nov 18, 25$32.00Nov 20, 25$31.28Nov 25, 25$32.37Nov 28, 25$32.50Dec 2, 25$32.44Dec 4, 25$30.70Dec 8, 25$31.31Dec 10, 25$29.48Dec 12, 25$30.35Dec 16, 25$29.44Dec 18, 25$28.66Dec 22, 25$26.49Dec 24, 25$27.88Dec 29, 25$25.92Jan 2, 26$26.37Jan 6, 26$26.01Jan 8, 26$27.89Jan 12, 26$28.38Jan 14, 26$28.32Jan 16, 26$27.05Jan 21, 26$26.39Jan 23, 26$26.48Jan 27, 26$25.59Jan 29, 26$25.00Feb 2, 26$23.17Feb 4, 26$24.15Feb 9, 26$23.61Feb 11, 26$24.60Feb 13, 26$23.82Feb 18, 26$24.69Feb 20, 26$24.93Feb 24, 26$25.00Feb 26, 26$24.10Mar 2, 26$23.66Mar 4, 26$22.25Mar 6, 26$23.14Mar 10, 26$24.49Mar 12, 26$24.00Mar 17, 26$24.40Mar 19, 26$22.04Mar 23, 26$22.32Mar 25, 26$22.38Mar 27, 26$23.04Mar 31, 26$23.87Apr 2, 26$27.32Apr 7, 26$27.33Apr 9, 26$25.88Apr 13, 26$25.45Apr 15, 26$27.09Apr 17, 26$27.40Apr 22, 26$25.13Apr 24, 26$23.95Apr 28, 26$23.00Apr 30, 26$22.88May 4, 26$22.02May 6, 26$21.57May 8, 26$21.50May 12, 26$21.16May 14, 26$20.18May 18, 26$18.56May 20, 26$19.78May 22, 26$21.01May 28, 26$19.88Jun 1, 26$19.08Jun 3, 26$17.87Jun 5, 26$17.20Jun 9, 26$17.07Jun 11, 26$17.11Jun 15, 26$17.34Jun 17, 26$17.09Jun 22, 26$17.13Jun 24, 26$17.08Jun 26, 26$16.77Jul 2, 26$18.50
$16.7752-week range$47.90
Loading valuation history…

Fundamentals

Key fundamentals

$1.9B

Market cap

-43.0%

Revenue growth (YoY)

76.4%

Gross margin

-$1.2B

Free cash flow (USD)

-$490.7M

Net debt

Net cash position

17.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$7.7MFY 2017$6.3MFY 2018$6.8MFY 2019$14.5MFY 2020$12.4MFY 2021$27.9MFY 2022$209.7MFY 2023$222.0MFY 2024$980.6MFY 2025$558.5M
$7.7M$558.5M

Free cash flow by year

2016 → 2025

FY 2016$-49.3MFY 2017$-128.5MFY 2018$-287.1MFY 2019$-541.7MFY 2020$-861.4MFY 2021$-1.0BFY 2022$-890.9MFY 2023$-782.9MFY 2024$-135.6MFY 2025$-1.2B
-$49.3M-$1.2B

Gross margin by year

2021 → 2025

FY 202188.1%FY 202289.5%FY 202386.2%FY 202497.0%FY 202576.4%
88.1%76.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 20-F filed Apr 29, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingFurther Grant of AwardsJun 30, 2026Filing
  • 6-K filingClinical Updates PresentationJun 15, 2026Filing
  • 6-K filingShare Purchase AnnouncementJun 12, 2026Filing
  • 6-K filingShare Purchase AnnouncementJun 10, 2026Filing
  • 6-K filingClinical Data PresentationJun 1, 2026Filing
  • 6-K filingPurchase of SharesMay 28, 2026Filing
  • 6-K filingPurchase of SharesMay 28, 2026Filing
  • 6-K filingGovernance UpdateMay 22, 2026Filing
  • 6-K filingClinical Advances PresentationMay 13, 2026Filing
  • 6-K filingInvestor Conference ParticipationMay 12, 2026Filing

Questions

Frequently asked questions

What is Ascentage Pharma Group International's market cap?

Ascentage Pharma Group International (AAPG) has a market capitalization of $1.9B.

What is AAPG's P/E ratio?

A meaningful P/E ratio is not available for AAPG — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying AAPG stock?

SEC Form 4 filings show no open-market insider buys at Ascentage Pharma Group International in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

BCRX

BioCryst Pharmaceuticals, Inc.

$1.9B

ZYME

Zymeworks Inc.

$1.9B

GLPG

Galapagos N.V.

$1.9B

ABCL

AbCellera Biologics Inc.

$1.9B

HRMY

Harmony Biosciences Holdings, Inc.

$1.8B

ADMA

ADMA Biologics, Inc.

$1.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.